Sofinnova Venture Partners VIII, L.P. Insider Trading
Get free email notifications about insider trading for Sofinnova Venture Partners VIII, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sofinnova Venture Partners VIII, L.P.. Sofinnova Venture Partners VIII, L.P. is a 10% Owner in Principia Biopharma Inc. ($PRNB) and a 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and a 10% Owner in Aclaris Therapeutics, Inc. ($ACRS).
Address: 2800 SAND HILL ROAD SUITE 150 MENLO PARK 94025 CA
Companies in which Sofinnova Venture Partners VIII, L.P. is an Insider
Aclaris Therapeutics, Inc.
Trading Symbol: ACRSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sofinnova Venture Partners VIII, L.P.: 10% Owner
Holdings: 2,289,480 shares
Current Value: $57,809,370
Latest Transaction: Oct 13 2015
$ACRS Market Capitalization: $537.94M
$ACRS Previous Close: $25.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Principia Biopharma Inc.
Trading Symbol: PRNBIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sofinnova Venture Partners VIII, L.P.: 10% Owner
Holdings: 625,482 shares
Latest Transaction: Sep 20 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNLOGIC, INC.
Trading Symbol: SYBXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sofinnova Venture Partners VIII, L.P.: 10% Owner
Holdings: 2,974,811 shares
Current Value: $6,544,584
Latest Transaction: Oct 06 2015
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sofinnova Venture Partners VIII, L.P.
Sentiment: All, ACRS, PRNB, SYBX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 167,537 | 0 | 0 | |
Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 453,954 | 0 | 0 | |
Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 521,235 | 0 | 0 | |
Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 625,482 | 0 | 0 | |
Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Buy | P | 17.00 | 270,000 | 4,590,000 | 2,038,208 | 1.8 M to 2 M (+15.27 %) |
Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Buy | C | 0.00 | 167,537 | 0 | 1,768,208 | 1.6 M to 1.8 M (+10.47 %) |
Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Buy | C | 0.00 | 453,954 | 0 | 1,600,671 | 1.1 M to 1.6 M (+39.59 %) |
View all Sofinnova Venture Partners VIII, L.P. insider transactions.